- |||||||||| Trial completion, Enrollment change, Trial primary completion date: TR NMD: Therapeutic Riding and Neuromuscular Disease (clinicaltrials.gov) - Oct 26, 2016
P1, N=60, Completed, Recruiting --> Completed | N=30 --> 60 | Trial primary completion date: Nov 2015 --> Oct 2016
- |||||||||| Trial primary completion date: Clinical Trial of a Serious Game for Individuals With SCI/D (clinicaltrials.gov) - Oct 25, 2016
P3, N=200, Recruiting, Enrolling by invitation --> Active, not recruiting | N=50 --> 63 | Trial primary completion date: Sep 2016 --> Dec 2016 Trial primary completion date: Apr 2016 --> Sep 2018
- |||||||||| venlafaxine extended release / Generic mfg.
Trial completion, Phase classification, Enrollment change, Trial primary completion date: Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury (clinicaltrials.gov) - Oct 13, 2016 P=N/A, N=34, Completed, Active, not recruiting --> Completed Recruiting --> Completed | Phase classification: P2 --> PN/A | N=16 --> 34 | Trial primary completion date: Jun 2011 --> Jun 2012
- |||||||||| Enrollment change, Trial termination, Trial primary completion date: Comparing Surgical Decompression Versus Conservative Treatment in Incomplete Spinal Cord Injury (clinicaltrials.gov) - Oct 13, 2016
P=N/A, N=1, Terminated, Recruiting --> Completed | Phase classification: P2 --> PN/A | N=16 --> 34 | Trial primary completion date: Jun 2011 --> Jun 2012 N=72 --> 1 | Recruiting --> Terminated | Trial primary completion date: Oct 2015 --> Jun 2015; only 1 inclusion in 1.5 years due to strict exclusion criteria
- |||||||||| Enrollment closed, Trial primary completion date: Power Over Pain (POP) Study (clinicaltrials.gov) - Sep 30, 2016
P=N/A, N=144, Active, not recruiting, Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2017 --> Feb 2018
- |||||||||| Trial primary completion date: Stem Cell Therapy in Spinal Cord Injury (clinicaltrials.gov) - Sep 26, 2016
P2, N=500, Recruiting, Withdrawn --> Completed Trial primary completion date: Dec 2014 --> Oct 2016
- |||||||||| Enrollment closed, Trial primary completion date: Re-Inventing Yourself After Spinal Cord Injury (clinicaltrials.gov) - Jul 26, 2016
P=N/A, N=81, Active, not recruiting, Trial primary completion date: Apr 2016 --> Apr 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Sep 2016
- |||||||||| HuCNS-SC / Microbot Medical
Enrollment change, Trial termination, Trial primary completion date: Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury (clinicaltrials.gov) - Jun 5, 2016 P2, N=31, Terminated, Enrolling by invitation --> Terminated | Trial primary completion date: Dec 2018 --> May 2016; Based on a business decision unrelated to any safety concerns. N=56 --> 31 | Recruiting --> Terminated | Trial primary completion date: May 2017 --> May 2016; Based on a business decision unrelated to any safety concerns.
- |||||||||| Trial initiation date: Tissue Bonding Cystostomy(TBC) (clinicaltrials.gov) - May 11, 2016
P1, N=10, Not yet recruiting, Trial primary completion date: Mar 2013 --> Mar 2012 Initiation date: Jan 2016 --> May 2017
- |||||||||| Trial primary completion date: Power Over Pain (POP) Study (clinicaltrials.gov) - Apr 14, 2016
P=N/A, N=144, Recruiting, Trial primary completion date: Dec 2015 --> Dec 2017 Trial primary completion date: Sep 2016 --> Jan 2017
- |||||||||| Epicyn / Sonoma Pharma, Amneal
Trial primary completion date: Pressure Ulcer Healing With Microcyn (clinicaltrials.gov) - Mar 9, 2016 P4, N=80, Recruiting, N=70 --> 53 Trial primary completion date: Feb 2016 --> Aug 2017
|